Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Albuterol administration is commonly associated with increases in serum lactate in patients with asthma treated for acute exacerbation of asthma.

Lewis LM, Ferguson I, House SL, Aubuchon K, Schneider J, Johnson K, Matsuda K.

Chest. 2014 Jan;145(1):53-59. doi: 10.1378/chest.13-0930.

PMID:
23949578
2.

Repeated dyspnea score and percent FEV1 are modest predictors of hospitalization/relapse in patients with acute asthma exacerbation.

Schneider JE, Lewis LM, Ferguson I, House SL, Liu J, Matsuda K, Johnson K.

Respir Med. 2014 Sep;108(9):1284-91. doi: 10.1016/j.rmed.2014.06.006. Epub 2014 Jul 8.

3.
4.

A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma.

Karpel JP, Schacter EN, Fanta C, Levey D, Spiro P, Aldrich T, Menjoge SS, Witek TJ.

Chest. 1996 Sep;110(3):611-6.

PMID:
8797400
6.

The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials.

Lanes SF, Garrett JE, Wentworth CE 3rd, Fitzgerald JM, Karpel JP.

Chest. 1998 Aug;114(2):365-72.

PMID:
9726716
8.

Effect of nebulized ipratropium on the hospitalization rates of children with asthma.

Qureshi F, Pestian J, Davis P, Zaritsky A.

N Engl J Med. 1998 Oct 8;339(15):1030-5.

9.

Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.

Levin DC, Little KS, Laughlin KR, Galbraith JM, Gustman PM, Murphy D, Kram JA, Hardie G, Reuter C, Ostransky D, McFarland K, Petty TL, Silvers W, Rennard SI, Mueller M, Repsher LH, Zuwallack RL, Vale R.

Am J Med. 1996 Jan 29;100(1A):40S-48S.

PMID:
8610716
10.

A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.

Nowak R, Emerman C, Hanrahan JP, Parsey MV, Hanania NA, Claus R, Schaefer K, Baumgartner RA; XOPENEX Acute Severe Asthma Study Group.

Am J Emerg Med. 2006 May;24(3):259-67.

PMID:
16635694
11.

Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma.

Schuh S, Johnson DW, Callahan S, Canny G, Levison H.

J Pediatr. 1995 Apr;126(4):639-45.

PMID:
7699549
12.

An evaluation of nebulized levalbuterol in stable COPD.

Datta D, Vitale A, Lahiri B, ZuWallack R.

Chest. 2003 Sep;124(3):844-9.

PMID:
12970007
14.

Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate-to-severe persistent asthma.

Gelb AF, Karpel J, Wise RA, Cassino C, Johnson P, Conoscenti CS.

Pulm Pharmacol Ther. 2008 Aug;21(4):630-6. doi: 10.1016/j.pupt.2008.02.005. Epub 2008 Mar 5.

PMID:
18403223
15.

Nebulized magnesium for moderate and severe pediatric asthma: A randomized trial.

Alansari K, Ahmed W, Davidson BL, Alamri M, Zakaria I, Alrifaai M.

Pediatr Pulmonol. 2015 Dec;50(12):1191-9. doi: 10.1002/ppul.23158. Epub 2015 Feb 4.

PMID:
25652104
16.
17.

The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma.

Hanania NA, Moore RH, Zimmerman JL, Miller CT, Bag R, Sharafkhaneh A, Dickey BF.

Respir Med. 2007 May;101(5):1007-14. Epub 2006 Oct 17.

20.

A randomized clinical trial of nebulized magnesium sulfate in addition to albuterol in the treatment of acute mild-to-moderate asthma exacerbations in adults.

Bessmertny O, DiGregorio RV, Cohen H, Becker E, Looney D, Golden J, Kohl L, Johnson T.

Ann Emerg Med. 2002 Jun;39(6):585-91.

PMID:
12023699

Supplemental Content

Support Center